Format

Send to

Choose Destination
EuroIntervention. 2016 Sep 18;12(Y):Y22-7. doi: 10.4244/EIJV12SYA6.

TAVI with current CE-marked devices: strategies for optimal sizing and valve delivery.

Author information

1
Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands.

Abstract

Transcatheter aortic valve implantation (TAVI) has evolved from an exclusive, highly complex and hazardous procedure into a mature, safe and streamlined therapy for patients with severe aortic stenosis (AS). Various successive device iterations and product refinements have created a dynamic and competitive field with a spectrum of different CE-marked transcatheter heart valve (THV) designs. This review provides a practical overview of current CE-marked THVs with a focus on respective sizing algorithms and delivery strategies.

PMID:
27640026
DOI:
10.4244/EIJV12SYA6
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Europa Digital & Publishing
Loading ...
Support Center